Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology

News   Sep 10, 2015

 
Aragen Bioscience Licenses Protein Production Technology from Proteonic Biotechnology
 
 
 

RELATED ARTICLES

CRISPR Screening Reveals Sickle Cell Disease Target

News

A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.

READ MORE

Synthetic Material That Detects Enzymatic Activity

News

Scientists integrate protein and polymer building blocks to create stimulus-responsive systems

READ MORE

New Target Protein for Colon Cancer Identified

News

Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy